
Galderma Launches Sculptra® in China, Further Fueling Its Growth Into One of the Fastest Growing Aesthetics Markets
ZUG, SWITZERLAND–(Business Wire / Korea Newswire)–Galderma today announced the launch of Sculptra, the first proven regenerative biostimulator with a unique poly-L-lactic acid (PLLA-SCA™) formulation, in China.[1]-[7],[11]-[14] This follows Sculptra’s approval by China’s National Medical Products Administration for correcting mid-facial volume